Abstract
DNA microarrays are high-throughput platforms that take advantage of the vast amount of sequence information and allow scientists to perform gene expression profiling or genotyping studies on a “global” or “genomewide” scale. The global monitoring of gene expression in hosts and pathogens, either separately or interactively, has given us systemic views of the disease mechanisms. Ongoing improvements in DNA sequencing and microarray technologies continue to open up new opportunities for better understanding and developing more effective approaches in diagnosis, treatments, and preventions of infectious diseases. This review focuses on the latest developments and applications of the DNA microarray technologies designed for studying pathogens in the areas of pathogenesis, host-pathogen interaction, drug response, vaccine development, and disease agent identification. Issues and challenges in the analysis, management and interpretation of microarray data are also addressed.
Keywords: DNA microarray, gene expression profiling, genotyping, infectious disease, pathogen genome project, data analysis, data management
Infectious Disorders - Drug Targets
Title: DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Volume: 6 Issue: 3
Author(s): T. Chen
Affiliation:
Keywords: DNA microarray, gene expression profiling, genotyping, infectious disease, pathogen genome project, data analysis, data management
Abstract: DNA microarrays are high-throughput platforms that take advantage of the vast amount of sequence information and allow scientists to perform gene expression profiling or genotyping studies on a “global” or “genomewide” scale. The global monitoring of gene expression in hosts and pathogens, either separately or interactively, has given us systemic views of the disease mechanisms. Ongoing improvements in DNA sequencing and microarray technologies continue to open up new opportunities for better understanding and developing more effective approaches in diagnosis, treatments, and preventions of infectious diseases. This review focuses on the latest developments and applications of the DNA microarray technologies designed for studying pathogens in the areas of pathogenesis, host-pathogen interaction, drug response, vaccine development, and disease agent identification. Issues and challenges in the analysis, management and interpretation of microarray data are also addressed.
Export Options
About this article
Cite this article as:
Chen T., DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century, Infectious Disorders - Drug Targets 2006; 6 (3) . https://dx.doi.org/10.2174/187152606778249962
DOI https://dx.doi.org/10.2174/187152606778249962 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Kawasaki Disease and Its Treatment – An Update
Current Rheumatology Reviews Thrombotic Microangiopathy and Occult Neoplasia
Cardiovascular & Hematological Disorders-Drug Targets Vaccines and Photodynamic Therapies for Oral Microbial-Related Diseases
Current Drug Metabolism Complementary Therapies in Inflammatory Bowel Diseases
Current Drug Targets Prevalence of Nasal Colonization with Staphylococcus aureus in Patients with Rheumatoid Arthritis
Current Rheumatology Reviews The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) New Antibiotics for Severe ICU-Aquired Bacterial Infections
Infectious Disorders - Drug Targets New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas
Current Pharmaceutical Design Bacteriophage and Peptidoglycan Degrading Enzymes with Antimicrobial Applications
Recent Patents on Biotechnology Cardiac Workup of Ischemic Stroke
Current Cardiology Reviews COVID-19 and the Challenges of Chemotherapy: The Failure Case of Hydroxychloroquine in the Clinical Treatment of SARS-CoV-2 Infection
Coronaviruses Macrolides Allergy
Current Pharmaceutical Design Pulmonary Embolism Response Team (PERT) - A New Paradigm for the Treatment of Pulmonary Embolism
Current Pharmaceutical Design Cardiovascular Magnetic Resonance for Evaluation of Heart Involvement in ANCA-Associated Vasculitis. A Luxury or a Valuable Diagnostic Tool?
Inflammation & Allergy - Drug Targets (Discontinued) Nuclear Imaging of Post-infarction Inflammation in Ischemic Cardiac Diseases - New Radiotracers for Potential Clinical Applications
Current Radiopharmaceuticals Coarctation of the Aorta - The Current State of Surgical and Transcatheter Therapies
Current Cardiology Reviews Prevention of Bacterial Endocarditis
Cardiovascular & Hematological Disorders-Drug Targets Antibiotic Treatment in Native Valve Infective Endocarditis
Infectious Disorders - Drug Targets Adenotonsillar Disease
Recent Patents on Inflammation & Allergy Drug Discovery Dendrimers and Dendritic Polymers as Anti-infective Agents: New Antimicrobial Strategies for Therapeutic Drugs
Anti-Infective Agents in Medicinal Chemistry